Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data - PubMed (original) (raw)
. 1997 Feb 7;70(4):375-82.
doi: 10.1002/(sici)1097-0215(19970207)70:4<375::aid-ijc1>3.0.co;2-t.
R J Lin, S L Stewart, R F Ambinder, R F Jarrett, P Brousset, G Pallesen, M L Gulley, G Khan, J O'Grady, M Hummel, M V Preciado, H Knecht, J K Chan, A Claviez
Affiliations
- PMID: 9033642
- DOI: 10.1002/(sici)1097-0215(19970207)70:4<375::aid-ijc1>3.0.co;2-t
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data
S L Glaser et al. Int J Cancer. 1997.
Abstract
Hodgkin's disease (HD) has long been suspected to have an infectious precursor, and indirect evidence has implicated Epstein-Barr virus (EBV), a ubiquitous herpesvirus, as a causal agent. Recent molecular studies using EBER in situ hybridization or latency membrane protein-I (LMP-I) immunohistochemistry have identified EBV latent infection in up to 50% of HD tumors. However, the epidemiologic features of these cases have not been examined in detail. To explore the epidemiology of EBV-positive HD so as to understand the role of EBV in HD etiology more clearly, this project accumulated patient data from 14 studies that had applied these EBV assays to HD tumors. With information on age at diagnosis, sex, ethnicity, histologic subtype, country of residence, clinical stage and EBV tumor status from 1,546 HD patients, we examined risk for EBV-positive disease using logistic regression. Forty percent of subjects had EBV-positive tumors, and EBV prevalence varied significantly across groups defined by the study variables. Odds ratios (OR) for EBV-associated HD were significantly elevated for Hispanics vs. whites (OR = 4.1), mixed cellularity vs. nodular sclerosis histologic subtypes (OR = 7.3, 13.4, 4.9 for ages 0-14, 15-49, 50+ years), children from economically less-developed vs. more-developed regions and young adult males vs. females (OR = 2.5). These findings suggest that age, sex, ethnicity and the physiologic effects of poverty may represent biologic modifiers of the EBV association and confirm that this association is strongly but variably linked to histologic subtype. The data augment biologic evidence that EBV is actively involved in HD pathogenesis in some cases but describe epidemiologic complexity in this process.
Similar articles
- A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection.
Huh J, Park C, Juhng S, Kim CE, Poppema S, Kim C. Huh J, et al. Cancer. 1996 Mar 1;77(5):949-55. doi: 10.1002/(sici)1097-0142(19960301)77:5<949::aid-cncr22>3.0.co;2-2. Cancer. 1996. PMID: 8608489 - Epstein-Barr virus expression in Hodgkin's disease in Jordan.
Almasri NM, Khalidi HS. Almasri NM, et al. Saudi Med J. 2004 Jun;25(6):770-5. Saudi Med J. 2004. PMID: 15195209 - Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype.
Zarate-Osorno A, Roman LN, Kingma DW, Meneses-Garcia A, Jaffe ES. Zarate-Osorno A, et al. Cancer. 1995 Mar 15;75(6):1360-6. doi: 10.1002/1097-0142(19950315)75:6<1360::aid-cncr2820750619>3.0.co;2-u. Cancer. 1995. PMID: 7882287 - Epstein Barr virus in Argentine pediatric Hodgkin's disease.
Preciado MV, Diez B, Grinstein S. Preciado MV, et al. Leuk Lymphoma. 1997 Jan;24(3-4):283-90. doi: 10.3109/10428199709039015. Leuk Lymphoma. 1997. PMID: 9156657 Review. - Epidemiology of EBV and Hodgkin's lymphoma.
Jarrett AF, Armstrong AA, Alexander E. Jarrett AF, et al. Ann Oncol. 1996;7 Suppl 4:5-10. doi: 10.1093/annonc/7.suppl_4.s5. Ann Oncol. 1996. PMID: 8836402 Review.
Cited by
- Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.
Levin LI, Chang ET, Ambinder RF, Lennette ET, Rubertone MV, Mann RB, Borowitz M, Weir EG, Abbondanzo SL, Mueller NE. Levin LI, et al. Blood. 2012 Nov 1;120(18):3750-5. doi: 10.1182/blood-2011-12-390823. Epub 2012 Sep 12. Blood. 2012. PMID: 22972983 Free PMC article. - Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.
Kapatai G, Murray P. Kapatai G, et al. J Clin Pathol. 2007 Dec;60(12):1342-9. doi: 10.1136/jcp.2007.050146. J Clin Pathol. 2007. PMID: 18042690 Free PMC article. Review. - Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.
Banerjee D. Banerjee D. Adv Hematol. 2011;2011:439456. doi: 10.1155/2011/439456. Epub 2011 Jan 18. Adv Hematol. 2011. PMID: 21318045 Free PMC article. - Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting.
Körber N, Behrends U, Protzer U, Bauer T. Körber N, et al. J Transl Med. 2020 Jun 17;18(1):242. doi: 10.1186/s12967-020-02385-x. J Transl Med. 2020. PMID: 32552697 Free PMC article. - Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma.
Adam M, Bekuretsion Y, Gebremedhin A, Kwiecinska A, Howe R, Petros B, Jerkeman M. Adam M, et al. J Clin Exp Hematop. 2023;63(4):230-239. doi: 10.3960/jslrt.23037. J Clin Exp Hematop. 2023. PMID: 38148013 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical